This move is archived. Current quotes and coverage live on the stock page.
Get APTX alerts:
Apotex Health Corp is seeing a significant rise in its stock price, which reflects growing investor confidence.
In the latest trading session, Apotex Health Corp (APTX.TO) saw its stock price increase by 4.75%, closing at CA$33.95. This uptick comes as the company strengthens its position in the pharmaceutical market, especially after recent strategic moves.
Advertisement
Apotex Health Corp
APTX.TO
APTX.TO
Apotex Health Corp
WealthAwesomeMarket cap
$7.40B
52W high
$40.18
52W low
$26.05
1W change
-3.05%
Analyst Price Targets
Based on analyst covering APTX
Wall Street analysts forecast APTX stock price to rise 27.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$41.34
+27.7% Upside
Current Price
C$32.37
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on APTX's historical volatility
30-Day Vol
42.6%
Annualized
90-Day Vol
48.9%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$38.70
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$34.36 | C$29.66 – C$39.80 |
| 60 trading days | C$36.46 | C$29.62 – C$44.89 |
| 90 trading days | C$38.70 | C$30.00 – C$49.92 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should pay attention to Apotex's recent performance and strategic initiatives, which may suggest a positive outlook for future growth.
Market Cap Reaches CA$7.87 Billion
With a market cap of CA$7,867,120,640, Apotex is a key player in the Canadian pharmaceutical landscape.
Bull case
The recent rise in stock price is backed by Apotex's expansion efforts and successful product approvals, which boost its market presence and potential revenue streams.
Bear case
Even with this positive movement, investors should stay cautious. Market volatility and competition in the pharmaceutical sector could affect future performance.
Recent Performance Highlights
Advertisement
In today's trading session, Apotex Health Corp's stock rose by 4.75%, closing at CA$33.95. This increase shows the company's growing appeal to investors, especially after its recent strategic transaction with Cumberland Pharmaceuticals, which is expected to enhance its U.S. market presence. For more insights on Apotex's journey, check out our detailed analysis on APTX.TO.
Strategic Moves Fueling Growth
Apotex's recent approval for SEVMIA™, a generic semaglutide for chronic weight management, positions it as a leader in the weight management solutions market. This approval, along with the successful upsizing of its IPO, reflects a strong growth strategy that may attract further investment. Investors can learn more about these developments on our APTX.TO page.
Looking Ahead
As Apotex Health Corp continues to expand its portfolio and enhance its market strategies, investors should watch for upcoming product launches and market developments. The company's ability to navigate competition and regulatory challenges will be crucial for maintaining its upward trajectory. For ongoing updates, visit our comprehensive coverage on APTX.TO.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
